Cross-Sector entity

GOOD Vision

Company
7

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention GOOD Vision oka³y ! ™, the most common co-covered peer. The tracked stories average 2 original sources each. GOOD Vision appears in 1 tracked Cross-Sector story from March 9, 2026.

1 verified story tracked

Last mentioned: Mar 9, 2026

Entity pulse

Recent coverage · GOOD Vision

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about GOOD Vision

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention GOOD Vision oka³y ! ™, the most common co-covered peer. The tracked stories average 2 original sources each. GOOD Vision appears in 1 tracked Cross-Sector story from March 9, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering GOOD Vision. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Global Debut

    Official international launch of the product in Geneva.

  2. Commercial Formation

    GOOD Vision established to bring the oka³y ! ™ system to market.

  3. Research & Development

    PolyU researchers refine freeform algorithms for orthokeratology.

Stories mentioning GOOD Vision 1

Healthcare medical devices Strongly positive 7

GOOD Vision oka³y ! ™ Debuts at Geneva: A New Era for Freeform Ortho-K

GOOD Vision has unveiled its 'oka³y ! ™' freeform orthokeratology system, a product of research from The Hong Kong Polytechnic University, at a global debut in Geneva. The technology aims to redefine precision in myopia control through advanced freeform lens design, transitioning from academic research to a commercial medical device.

2 sources

Source: itnewsonline.com · businessdayghana.com